Affiliation:
1. Penza State University
2. Saratov State University named after V.I. Razumovsky
Abstract
Purpose of the study: to establish the clinical and diagnostic signifi cance of structural and functional changes in the colon in NAFLD against the background of obesity, type 2 diabetes, arterial hypertension.Materials and methods: 138 patients with NAFLD and intestinal pathology, 36 patients without intestinal dysfunction were examined. The clinical and endoscopic features of lesions of the colon mucosa in patients with NAFLD were studied, taking into account the underlying pathology (obesity, type 2 diabetes, arterial hypertension). Changes in intestinal microbiocenosis were revealed in patients with NAFLD, depending on the underlying pathology. The morphometric parameters of the expression of colonocytes immunopositive to the vascular endothelial growth factor, as well as to leptin, were studied in comparison with the clinical and endoscopic features of the colon and liver, and the presence of a background disease.Results: It has been established that the background diseases in NAFLD — type 2 diabetes and obesity — make a certain contribution to the structural and functional changes in the colon. In turn, changes in the intestinal microbiota in NAFLD against the background of obesity, type 2 diabetes lead to aggravation of dyslipidemia, glycemia with the progression of chronic systemic infl ammation and fi brosis in the liver.
Publisher
LLC Global Media Technology
Subject
Gastroenterology,Hepatology
Reference23 articles.
1. Gadaleta R. M., Cariello M., Sabbà C., Moschetta A. Tissue-s pecifi c actions of FXR in metabolism and cancer. Biochim Biophys Acta. 2015; 185 (1): 30–39. doi:10.1016/j.bbalip.2014.08.005
2. Piper M. S., Saad R. G. Diabetes Mellitus and the Colon. Curr Treat Options Gastroenterol. 2017; 15 (4): 460–474. doi:10.1007/s11938–017–0151–1
3. Anisimova E. V., Kozlova I. V., Volkov S. V. Pathology of digestive organs at adiposity (review). Saratov Journal of Medical Scientifi c Research. 2011; 7(4): 851–856. (in Russ.)
4. DiBaise J.K., Zhang H., Crowell M. D., Krajmalnik- Brown R., Decker G. A., Rittmann B. E. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc. 2008;83(4):460–469. doi:10.4065/83.4.460
5. Zaharenko S. M., Fominyh Yu.A., Mekhtiev S. N. [Infections, human gut microbiota and metabolic syndrome]. Eff ective Pharmacotherapy. 2011; 3:14–22. (in Russ.)